Filed: 5/14/2024ACC: 0000950123-24-005045
📋 What this filing means
OMEGA FUND MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 11 equity positions with a total reported market value of $155.01M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
11
Positions
$155.01M
Total AUM (reported)
27.11M
Total Shares
Allocation by class
COMMON STOCK$101.91M65.7%
COMMON STOCK CLASS A$51.22M33.0%
WARRANT$1.88M1.2%
Portfolio Concentration
Top 3$112.68M72.7%
4–10$41.08M26.5%
11–25$1.24M0.8%
Top 3 weight
72.7%
Top 10 weight
99.2%
Voting Authority Distribution
Total shares with voting rights: 27.11M
Sole
Full voting authority
27.11M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole11
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings11
Rows:
Nuvation Bio
SOLEShares14.07M
TypeSH
Market value$51.22M
33.05%
Sole
14.07M
Shared
0.00
None
0.00
Lexeo Therapeutics
SOLEShares2.36M
TypeSH
Market value$36.94M
23.83%
Sole
2.36M
Shared
0.00
None
0.00
Replimune Group
SOLEShares3M
TypeSH
Market value$24.52M
15.82%
Sole
3M
Shared
0.00
None
0.00
enGene Holdings Inc.
SOLEShares1.08M
TypeSH
Market value$18.24M
11.77%
Sole
1.08M
Shared
0.00
None
0.00
Sana Biotechnology, Inc.
SOLEShares843.75K
TypeSH
Market value$8.44M
5.44%
Sole
843.75K
Shared
0.00
None
0.00
Morphic Holding
SOLEShares159.85K
TypeSH
Market value$5.63M
3.63%
Sole
159.85K
Shared
0.00
None
0.00
Ikena Oncology
SOLEShares2.25M
TypeSH
Market value$3.19M
2.06%
Sole
2.25M
Shared
0.00
None
0.00
Immunic Inc
SOLEShares1.79M
TypeSH
Market value$2.36M
1.52%
Sole
1.79M
Shared
0.00
None
0.00
enGene Holdings Inc.
SOLEShares360.90K
TypeSH
Market value$1.88M
1.21%
Sole
360.90K
Shared
0.00
None
0.00
Syros Pharmaceuticals
SOLEShares251.27K
TypeSH
Market value$1.34M
0.87%
Sole
251.27K
Shared
0.00
None
0.00
Kronos Bio
SOLEShares955.87K
TypeSH
Market value$1.24M
0.80%
Sole
955.87K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Nuvation BioSOLE | Common Stock Class A | 14.07M | SH | $51.22M 33.05% | 14.07M | 0.00 | 0.00 |
Lexeo TherapeuticsSOLE | Common Stock | 2.36M | SH | $36.94M 23.83% | 2.36M | 0.00 | 0.00 |
Replimune GroupSOLE | Common Stock | 3M | SH | $24.52M 15.82% | 3M | 0.00 | 0.00 |
enGene Holdings Inc.SOLE | Common Stock | 1.08M | SH | $18.24M 11.77% | 1.08M | 0.00 | 0.00 |
Sana Biotechnology, Inc.SOLE | Common Stock | 843.75K | SH | $8.44M 5.44% | 843.75K | 0.00 | 0.00 |
Morphic HoldingSOLE | Common Stock | 159.85K | SH | $5.63M 3.63% | 159.85K | 0.00 | 0.00 |
Ikena OncologySOLE | Common Stock | 2.25M | SH | $3.19M 2.06% | 2.25M | 0.00 | 0.00 |
Immunic IncSOLE | Common Stock | 1.79M | SH | $2.36M 1.52% | 1.79M | 0.00 | 0.00 |
enGene Holdings Inc.SOLE | Warrant | 360.90K | SH | $1.88M 1.21% | 360.90K | 0.00 | 0.00 |
Syros PharmaceuticalsSOLE | Common Stock | 251.27K | SH | $1.34M 0.87% | 251.27K | 0.00 | 0.00 |
Kronos BioSOLE | Common Stock | 955.87K | SH | $1.24M 0.80% | 955.87K | 0.00 | 0.00 |